Rwegerera Godfrey Mutashambara
University of Botswana, School of Medicine, Gaborone, Botswana.
Pan Afr Med J. 2014 Apr 7;17:252. doi: 10.11604/pamj.2014.17.252.2972. eCollection 2014.
Adherence to diabetes mellitus treatment regimens among Type 2 diabetes patients in Tanzania has not been well documented. This study sought to assess adherence to antidiabetic drugs and associated factors among patients with Type 2 diabetes mellitus.
A cross-sectional study was conducted among type 2 diabetes mellitus patients who were attending the Diabetic clinic of Muhimbili National hospital between May 2009 and February 2010. Assement of adherence to antidiabetic medications was based on patients' self-reported recall of skipped days without taking medications, over the past one week and three months. Data were entered and analyzed using Statistical Package for Social Sciences (SPSS Inc. Chicago, Illinois version 16). The crude and adjusted odds ratio (COR/ AOR) and 95% Confidence Interval (CI) were performed to determine factors associated with anti-diabetic medications adherence and a p-value of 0.05 or less was considered statistically significant.
Adherence rates to antidiabetic drugs were found to be 60.2% and 71.2% at one week and three months respectively. High cost of medication was significantly associated with anti-diabetic non-adherence. Adherence to anti-diabetic drugs significantly increased with an increase in number of non-diabetic medications.
Adherence to antidiabetic drugs was found to be suboptimal. Patients with other medical conditions in addition to diabetes mellitus are more likely to adhere to anti-diabetic medications. There is a need for the responsible authorities to set policies that subsidize cost of anti-diabetic drugs to improve adherence and reduce associated complications.
坦桑尼亚2型糖尿病患者对糖尿病治疗方案的依从性尚无充分记录。本研究旨在评估2型糖尿病患者对抗糖尿病药物的依从性及相关因素。
于2009年5月至2010年2月期间,对在穆希姆比利国家医院糖尿病诊所就诊的2型糖尿病患者进行了一项横断面研究。基于患者对过去一周和三个月内未服药天数的自我报告回忆,评估其对抗糖尿病药物的依从性。使用社会科学统计软件包(SPSS Inc.,伊利诺伊州芝加哥第16版)录入和分析数据。计算粗比值比和调整比值比(COR/AOR)以及95%置信区间(CI),以确定与抗糖尿病药物依从性相关的因素,p值小于或等于0.05被认为具有统计学意义。
发现抗糖尿病药物的一周和三个月依从率分别为60.2%和71.2%。药物成本高与抗糖尿病治疗不依从显著相关。随着非糖尿病药物数量的增加,抗糖尿病药物的依从性显著提高。
发现抗糖尿病药物的依从性欠佳。除糖尿病外还患有其他疾病的患者更有可能坚持服用抗糖尿病药物。负责部门需要制定补贴抗糖尿病药物成本的政策,以提高依从性并减少相关并发症。